Revolution Medicines, Inc. RVMD Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Revolution Medicines, Inc.’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s price / sales?
- Revolution Medicines, Inc. (RVMD) reported price / sales of 10,197.3× in Q3 2024.
- How has Revolution Medicines, Inc.'s price / sales changed year-over-year?
- Revolution Medicines, Inc.'s price / sales increased by 8725.4% year-over-year, from 115.5× to 10,197.3×.
- What is the long-term trend for Revolution Medicines, Inc.'s price / sales?
- Over 2 years (2021 to 2023), Revolution Medicines, Inc.'s price / sales has grown at a 51.9% compound annual growth rate (CAGR), from 273.3× to 630.7×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.